Serum Interleukin 6, Controlling Nutritional Status (CONUT) Score and Phase Angle in Patients with Crohn’s Disease

• Published in: Nutrients Vol. 15; no. 8; p. 1953
• Main Authors: Cioffi, Iolanda, Scialò, Filippo, Di Vincenzo, Olivia, Gelzo, Monica, Marra, Maurizio, Testa, Anna, Castiglione, Fabiana, Vitale, Maria, Pasanisi, Fabrizio, Santarpia, Lidia
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 18.04.2023; MDPI
• Subjects: Adult; adults; Anthropometry; Biomarkers; blood serum; Body composition; Body mass index; C-reactive protein; Classification; Complications and side effects; Crohn Disease - complications; Crohn Disease - drug therapy; Crohn's disease; Cytokines; Development and progression; digestive tract; Evaluation; Health aspects; Hospitals; Humans; Inflammation; Inflammation - complications; Interleukin-6; Malnutrition; Malnutrition - complications; Measurement; medical treatment; Middle Aged; Nutrition Assessment; Nutritional Status; Ostomy; Prognosis; Protein-Energy Malnutrition - complications; Remission (Medicine); Retrospective Studies; risk; Risk factors; Surgery; Young Adult; Italy; Canada; Montreal Quebec Canada; United States > US; c reactive protein; malnutrition; phase angle; inflammatory bowel disease; CONUT score
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu15081953

Crohn’s disease (CD) is a chronic inflammatory disorder that may occur in any segment of the gastrointestinal tract. Asymptomatic or untreated inflammation along with malnutrition can often coexist in patients with CD, impairing clinical outcomes, therefore the aim of this study was to assess the relationship between inflammation, malnutrition risk and nutritional status in CD patients. Consecutive adult CD outpatients aged 18-65 years were recruited. Disease activity was clinically defined by the Crohn’s Disease Activity Index (CDAI), whilst anthropometry and phase angle (PhA) were measured. The Controlling Nutritional Status (CONUT) score was retrospectively calculated for screening malnutrition risk and blood samples were taken. A total of 140 CD patients with a mean age of 38.8 ± 13.9 years and an average weight of 64.9 ± 12.0 kg were included. Serum interleukin (IL)-6 concentration was increased in active-CD patients, unrelated to medical treatment, which was associated with CDAI and PhA. Based on the CONUT score, the prevalence of patients with moderate/severe malnutrition risk (score ≥ 5) was 10%, showing lower age, body mass index and fat mass, but higher IL-6 and IL-1β levels than subjects classified as not at risk (score 0–1). Finally, increased IL-6 levels and reduced PhA values were identified as independent predictors of moderate/severe malnutrition risk (p < 0.05). In conclusion, IL-6 increased in active-CD patients, which was inversely correlated with PhA. Although the CONUT score might be helpful for identifying CD patients at moderate/severe risk of malnutrition, larger studies are needed to verify these results in different settings.